This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saini, S.
Right arrow Articles by Rao, C. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saini, S.
Right arrow Articles by Rao, C. V.

 Previous Article  |  Next Article 

Journal of Bacteriology, May 2009, p. 3003-3010, Vol. 191, No. 9
0021-9193/09/$08.00+0     doi:10.1128/JB.01694-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Role of FimW, FimY, and FimZ in Regulating the Expression of Type I Fimbriae in Salmonella enterica Serovar Typhimurium{triangledown}

Supreet Saini,§ Jeffrey A. Pearl,§ and Christopher V. Rao*

Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801

Received 4 December 2008/ Accepted 6 February 2009


arrow
ABSTRACT
 
Type I fimbriae in Salmonella enterica serovar Typhimurium are surface appendages that facilitate binding to eukaryotic cells. Expression of the fim gene cluster is known to be regulated by three proteins—FimW, FimY, and FimZ—and a tRNA encoded by fimU. In this work, we investigated how these proteins and tRNA coordinately regulate fim gene expression. Our results indicate that FimY and FimZ independently activate the PfimA promoter which controls the expression of the fim structural genes. FimY and FimZ were also found to strongly activate each other's expression and weakly activate their own expression. FimW was found to negatively regulate fim gene expression by repressing transcription from the PfimY promoter, independent of FimY or FimZ. Moreover, FimW and FimY interact within a negative feedback loop, as FimY was found to activate the PfimW promoter. In the case of fimU, the expression of this gene was not found to be regulated by FimW, FimY, or FimZ. We also explored the effect of fim gene expression on Salmonella pathogenicity island 1 (SPI1). Our results indicate that FimZ alone is able to enhance the expression of hilE, a known repressor of SPI1 gene expression. Based on our results, we were able to propose an integrated model for the fim gene circuit. As this model involves a combination of positive and negative feedback, we hypothesized that the response of this circuit may be bistable and thus a possible mechanism for phase variation. However, we found that the response was continuous and not bistable.


arrow
INTRODUCTION
 
Type I fimbriae in Salmonella enterica serovar Typhimurium are proteinaceous surface appendages that carry adhesions specific for mannosylated glycoproteins (9). Type I fimbriae are involved in serovar Typhimurium pathogenicity by facilitating the binding to and invasion of intestinal epithelial cells (43). In orally inoculated mice, a wild-type strain has been shown to cause more infections and deaths than a fim mutant strain (18). A fim mutant has also been shown to exhibit severalfold weaker binding to HEp-2 and HeLa cells, and the defect in binding could be restored by complementing the fim system on a plasmid (4). Apart from type I fimbriae, mutations in different Salmonella fimbrial systems—lpf, pef, and agf—have all also been shown to greatly reduce virulence in mice (47). These systems appear to work synergistically in order to facilitate colonization of the ileum (5). In serovar Typhimurium, the fim gene cluster possesses all of the genes necessary for type I fimbrial production. This gene cluster is composed of six structural genes, three regulators, and a tRNA specific for rare arginine codons (AGA and AGG). The structural genes fimA, fimI, fimC, fimD, fimH, and fimF are all expressed in one transcript from the PfimA promoter (26, 36-38). The regulators fimZ, fimY, and fimW are all expressed from independent promoters (44, 46, 48). The tRNA encoded by fimU is located at one end of the cluster and is required for the effective translation of the regulatory genes that all carry rare arginine codons (42).

Type I fimbriation is environmentally regulated with fim gene expression favored in static liquid medium, whereas growth on solid medium inhibits expression (17). Moreover, serovar Typhimurium cultures in fimbriae-inducing conditions contain cells in both fimbriated and nonfimbriated states (35). While the regulation of fim gene expression has been studied extensively in Escherichia coli, far less is known about the regulation in serovar Typhimurium (1, 27). In particular, despite homology between the structural genes for type I fimbriae in E. coli and serovar Typhimurium, their expression is regulated in completely different manners. No homologs of E. coli regulators, FimB and FimE, are present in serovar Typhimurium (24, 28). Also, the serovar Typhimurium PfimA promoter is inactive in E. coli, indicating that the PfimA promoter is regulated by different factors in these two organisms (48). In serovar Typhimurium, the expression of the structural genes is regulated by three transcription factors, FimY, FimZ, and FimW (44, 46, 48). Both FimZ and FimY are essential for the expression of the structural genes from the PfimA promoter (48). In particular, the deletion of either the fimY or fimZ gene reduces expression from the PfimA promoter and prevents serovar Typhimurium from making type I fimbriae. FimZ has been shown to bind the PfimA promoter and promote transcription (13, 48). FimY, on the other hand, is thought to facilitate the activation of the PfimA promoter, as direct binding has not been observed (44). FimW is a negative regulator of fim gene expression (45). FimW has also been suggested to autoregulate its expression, as enhanced PfimW activity has been observed in the {Delta}fimW mutant. In DNA-binding assays, FimW was not observed to bind any of the fim promoters. However, FimW was found to interact with FimZ in a LexA-based two-hybrid system in E. coli (45). Thus, a possible mechanism for FimW-mediated repression may be that it binds FimZ and prevents it from activating transcription. However, an analysis of the FimW amino acid sequence predicts that it has a DNA-binding domain. Moreover, it is related to a broad range of prokaryotic transcription factors, with its closest relatives being BpdT from Rhodococcus spp. and an uncharacterized response regulator, TodD, from Pseudomonas putida (29, 30). Thus, FimW may also act by an alternate mechanism involving DNA binding.

In addition to these transcription factors, the fimU tRNA also plays a role in fim gene expression (42). All three regulators—FimZ, FimY, and FimW—contain a number of the rare arginine codons, AGA and AGG, recognized by the fimU tRNA. In the case of FimY, {Delta}fimU mutants have been shown to be nonfimbriated due to the inefficient translation of fimY mRNA. This translational regulation results from FimY having three rare arginine codons within its first 14 amino acids. The phenotypic effect of the {Delta}fimU mutation could, however, be overcome by expressing fimU from a plasmid or by changing these three rare arginine codons in fimY to ones more efficiently translated.

As a pathogen, serovar Typhimurium invades host cells by a process in which effector proteins are injected into the target cells with the help of the Salmonella pathogenicity island 1 (SPI1) type III secretion system (12, 14). SPI1 gene expression is regulated by a number of proteins, with the critical activator being HilA (2). The expression of hilA, in turn, is regulated by three AraC-like transcriptional activators, hilC, hilD, and rtsA (19, 21, 22, 32, 40, 41). HilD activity is controlled by HilE; this protein binds HilD and is thought to prevent it from activating the PhilA promoter (6, 8). FimY and FimZ have been previously shown to regulate SPI1 gene expression by repressing hilA expression through their activation of the PhilE promoter (7).

In this work, we investigated the gene circuit regulating fim expression. Using genetic approaches, we found that FimZ and FimY activate each other's expression and that each protein can independently activate the PfimA promoter. Moreover, FimZ and FimY were found to be weak autoactivators. Our data also suggest that FimW-mediated repression occurs at the level of fimY transcription. With regard to fimU, we found that none of the fim regulatory genes had any effect on its transcription. As the fim gene circuit involves a combination of positive and negative feedback, we tested whether induction was bistable. However, we found the cell population responded homogeneously when induced. Finally, we looked at the link between the fim and SPI1 gene circuits and found that the PhilE promoter is activated solely by FimZ. Collectively, these results allow us to propose an integrated model for the regulation of the fim gene circuit in serovar Typhimurium.


arrow
MATERIALS AND METHODS
 
General techniques and growth conditions. All culture experiments were performed in Luria-Bertani (LB) broth (10 g/liter tryptone, 5 g/liter yeast extract, and 10 g/liter NaCl) at 37°C unless otherwise noted. Antibiotics were used at the following concentrations: ampicillin at 100 µg/ml, chloramphenicol at 20 µg/ml, and kanamycin at 40 µg/ml. All experiments involving the growth of cells carrying pKD46 were performed at 30°C as previously described (15). Loss of the helper plasmid pKD46 was achieved by growth in nonselective conditions on LB agar at 42°C. The removal of the antibiotic cassette from the FLP recombinant target (FRT)-chloramphenicol/kanamycin-FRT insert was obtained by the transformation of pCP20 into the respective strain and selection on ampicillin at 30°C. The loss of the helper plasmid pCP20 was obtained by growth at 42°C under nonselective conditions on LB agar (10). Integrations into the {lambda}attB sites of the serovar Typhimurium and E. coli genomes were done using the helper plasmid pInt-ts as described previously (25). The loss of the helper plasmid pInt-ts was obtained by growth at 42°C under nonselective conditions. Primers were purchased from IDT, Inc. Enzymes were purchased from New England Biolabs and Fermentas and used according to the manufacturer's recommendations.

Strain and plasmid construction. All bacterial strains and plasmids used in this study are described in Tables 1 and 2, respectively. All serovar Typhimurium strains are isogenic derivatives of strain 14028 (American Type Culture Collection [ATCC]). The generalized transducing phage of serovar Typhimurium P22 HT105/1int-201 was used in all transductional crosses (16).


View this table:
[in this window]
[in a new window]

 
TABLE 1. Strains used during this study


View this table:
[in this window]
[in a new window]

 
TABLE 2. Plasmids used during this study

The plasmids pKD3 and pKD4 were used as templates to generate scarred FRT mutants as described previously (14). The {Delta}fimYZ mutant was made using primers SS105F and SS105R. The {Delta}fimZ mutant was made using primers SS105FII and SS105F. The {Delta}fimY mutant was made using the primers SS105RII and SS105R. The {Delta}fimW mutant was made using primers SS152F and SS152R. The {Delta}fimU mutant was made using the primers SS165F and SS165R. All mutations were checked by PCR using primers that bound outside the deleted region. Prior to the removal of the antibiotic resistance marker, the constructs resulting from this procedure were moved into a clean wild-type background (14028) by P22 transduction.

In order to construct the fluorescent Venus reporter plasmid (34), PCR was used to amplify Venus from pBS7 using primers LC294F and LC296R. The resulting PCR product was used as a template with primers LC295F and LC296R to add three out-of-frame stop codons and a synthetic Shine-Dalgarno sequence before the Venus start codon. The resultant PCR product was then digested with EcoRI and HindIII and subcloned into the EcoRI and HindIII cut sites of pQE80L (Qiagen), yielding pQE80L-Venus. The plasmid pQE80L was digested with EcoRI and NheI, and the fragment was cloned into the conditional-replication, integration, and modular (CRIM) plasmid pAH125 digested with EcoRI and NheI (25). The resulting CRIM plasmid was called pVenus. Venus transcriptional fusions were made by amplifying the promoter of interest and then cloning these PCR fragments into the multiple cloning site of pVenus. The fimA transcriptional fusion was made using primers SS104F and SS104R. The fimY transcriptional fusion was made using primers SS037F and SS037R. The fimZ transcriptional fusion was made using primers SS103F and SS103R. The fimW transcriptional fusion was made using primers SS154F and SS154R. The fimU transcriptional fusion was made using primers SS162F and SS162R. The hilE transcriptional fusion was made using primers SS024F and SS024R. The PCR fragments were then digested with KpnI and EcoRI (sequences underlined) and cloned into the multiple cloning site of the pVenus vector. The resulting transcriptional fusions were integrated into the serovar Typhimurium and E. coli chromosomes at the {lambda}attB site using {lambda}Int produced from the CRIM helper plasmid pInt-ts, thus creating single-copy transcriptional fusions. In the case of serovar Typhimurium, the integrated plasmid was moved into different mutant strains by P22 transduction.

Expression plasmids for fimY, fimZ, and fimW were made by cloning the respective gene into the multiple cloning site of pPROTet.E (Clontech) under the control of a strong promoter, PLTetO-1, resulting in plasmids pFimY, pFimZ, and pFimW (33). The plasmid pFimZ was made first by amplifying the fimZ gene using the primers SS106F and SS106R. The PCR product was then digested with EcoRI and KpnI and cloned into pPROTet.E. The plasmid pFimY was made by amplifying the fimY gene using the primers SS107F and SS107R. The PCR product was then digested with SalI and BamHI and cloned into pPROTet.E. The plasmid pFimW was made by amplifying the fimW gene using the primers SS160F and SS160R. The PCR product was then digested with EcoRI and HindIII and cloned into pPROTet.E. In order to mutate the first three arginine rare codons at positions 7, 9, and 14 in fimY, primers SS162F and SS107R were used to amplify fimY with the rare arginine codons mutated to consensus arginine codons. The resulting PCR product was used as a template with primers SS167F and SS107R. The amplified product was digested with EcoRI and BamHI and cloned into the multiple cloning site of pPROTet.E. The plasmid is called pFimY*.

In our expression plasmids, in the absence of TetR, the PLTetO-1 promoter is constitutively active. To regulate the expression levels from the PLTetO-1 promoter, the tetR gene was also cloned downstream of the gene target into the plasmids as previously described (39). In this arrangement, in the absence of the inducer anhydrotetracycline (aTc), expression from the promoter is inhibited due to TetR. The inhibition, however, is relieved upon the addition of 100 ng/ml of aTc, and expression from the PLTetO-1 promoter then takes place. All constructs were sequenced prior to transforming into the wild-type and mutant strains. The sequences for all the primers used in this study are given in Table 3.


View this table:
[in this window]
[in a new window]

 
TABLE 3. List of primers used in the study

Fluorescence assays. As an indirect measure of gene expression, end-point and dynamic measurements of the fluorescent reporter system were made using a Tecan Safire2 microplate reader. For fluorescence end-point measurements, 1 ml culture was grown at 37°C overnight and then subcultured 1:1,000 in fresh medium and grown in static conditions for 24 h at 37°C. A total of 100 µl of the culture was then transferred to a 96-well microplate, and the relative fluorescence and optical density at 600 nm (OD600) measured. The fluorescence readings were normalized with the OD600 to account for cell density. For time course measurements, overnight cultures at 37°C were subcultured to an OD of 0.05 in fresh medium and allowed to grow to an OD of 0.15. A total of 100 µl of the culture was then transferred to a 96-well microplate and overlaid with 25 µl of oil to prevent evaporation. The temperature was maintained at 37°C, and fluorescence and OD readings were taken every 5 min. All experiments were done in triplicate and average values with the standard deviations reported.

Single-cell measurements were done similarly by growing the cells in noninducing conditions with vigorous shaking at 37°C. Overnight cultures were subcultured to an OD of 0.05 in fresh medium (LB) and grown in inducing conditions of high oxygen and no shaking at 37°C. Samples were collected at different time points by spinning the cells down, resuspending them in phosphate-buffered saline supplemented with chloramphenicol (34 µg/ml) to stop all translation and arrest the cells in their respective state, and finally storing on ice. All flow cytometry experiments were performed on a BD LRS II system (BD Biosciences). The data extraction and analysis for the flow cytometry experiments were done using FCS Express version 3 (De Novo Software).


arrow
RESULTS
 
FimZ and FimY are activators and FimW is a repressor of fim gene expression. FimZ and FimY have previously been reported as activators of fim gene expression in serovar Typhimurium (44, 48). Both have also been reported as essential for fimbriation, as the deletion of either one results in the loss of expression from the PfimA promoter (49). To understand the roles of FimZ and FimY in the fim gene circuit, we measured expression from the PfimA, PfimZ, PfimY, and PfimW promoters in the wild type and the {Delta}fimZ, {Delta}fimY, {Delta}fimYZ, and {Delta}fimW mutants (Fig. 1). Chromosomally integrated Venus transcriptional reporters were employed as indirect measures of promoter activities (34). In the cases of all four promoters, activity levels were found to be about two times less active in the {Delta}fimZ, {Delta}fimY, and {Delta}fimYZ mutants than in the wild type. For all four promoters, note that no further reduction in promoter activity was observed in the double mutant. In a {Delta}fimW mutant, the activities of all four promoters were approximately two times higher than the wild-type levels. While these results agree with previously published data regarding the fim system in serovar Typhimurium, they still do not tell us how FimW, FimY, and FimZ individually contribute to PfimA activation.


Figure 1
View larger version (18K):
[in this window]
[in a new window]

 
FIG. 1. FimY and FimZ are activators and FimW is a repressor of fim gene expression. Shown is a comparison of the PfimA, PfimY, PfimZ, and PfimW promoter activities in the wild type and the {Delta}fimY, {Delta}fimZ, {Delta}fimYZ, and {Delta}fimW mutants. Data are averages of the results from three experiments. Each experiment was done in triplicate.

FimY and FimZ are strong activators of each other's expression and weak activators of their own expression. To determine the relative effect of FimY and FimZ on fim gene expression, the PfimY and PfimZ promoter activities were measured in a {Delta}fimYZ mutant in which either FimZ or FimY was expressed from a strong, aTc-inducible promoter on a plasmid (see Materials and Methods). Using this system, we found that expressing FimZ in the {Delta}fimYZ mutant led to a more than 10-fold increase in PfimY activity (Fig. 2A). Likewise, expressing FimY in the {Delta}fimYZ mutant led to about a 10-fold increase in PfimZ levels. In addition to their ability to activate each other's promoters, FimY and FimZ were found to increase expression from their own promoters roughly threefold.


Figure 2
View larger version (12K):
[in this window]
[in a new window]

 
FIG. 2. FimY and FimZ are strong activators of each other's expression and also weak autoactivators. Shown is a comparison of the PfimY and PfimZ promoter activities in a serovar Typhimurium {Delta}fimYZ mutant (A) and E. coli (B) in which FimY and FimZ are independently expressed from an aTc-inducible promoter on a plasmid. Note that tetR is also expressed from this plasmid in order to achieve aTc-inducible expression. Data are averages of the results from three experiments. Each experiment was done in triplicate.

Even though E. coli makes type I fimbriae, the serovar Typhimurium fim promoters by themselves are inactive in this organism. Therefore, we performed an identical set of experiments with E. coli using the serovar Typhimurium proteins and promoters. Overall, the results were identical to those for serovar Typhimurium (Fig. 2B). In particular, FimZ expression led to a more than 10-fold increase in PfimY promoter activity, and FimY expression led to a 10-fold increase in PfimZ activity. Both FimZ and FimY were again found to weakly activate expression from their own promoters. The goal of these experiments was to remove the effect of any serovar Typhimurium-specific regulatory mechanisms, thus allowing us to more confidently conclude that the observed results are due to direct interactions. Collectively, these results show that FimY and FimZ strongly activate each other's expression and weakly activate their own expression. This cross-regulation also explains why both FimY and FimZ are required for strong PfimA promoter activity, as the expression of each is dependent on the other.

FimZ and FimY can independently activate expression from the PfimA promoter. Next, we looked at how FimZ and FimY independently affected PfimA expression. To investigate this problem, we measured PfimA promoter activity in a {Delta}fimYZ mutant in which either FimY or FimZ was expressed using the aTc-inducible system. FimZ expression was found to strongly (>15-fold) activate the PfimA promoter, whereas FimY could only weakly (more than twofold) activate it (Fig. 3). We also performed these experiments with E. coli with similar results (data not shown). Based on these results, we conclude that FimZ and FimY can both independently activate the PfimA promoter. In the case of FimY, the weak activation of the PfimA promoter is likely due to its strong dependence on fimU tRNA (see below) (42).


Figure 3
View larger version (11K):
[in this window]
[in a new window]

 
FIG. 3. FimY and FimZ can independently activate expression from the PfimA promoter. Shown is a comparison of PfimA promoter activities in a {Delta}fimYZ mutant in which FimY and FimZ are independently expressed from an aTc-inducible promoter on a plasmid. Data are averages of the results from three experiments. Each experiment was done in triplicate.

FimY activates the PfimW promoter, and FimW represses the PfimY promoter. FimW has previously been observed to repress fim gene expression (45). Consistent with these results, we observed that PfimA, PfimW, PfimY, and PfimZ promoter activities were all elevated in a {Delta}fimW mutant (Fig. 1). To understand the mechanism of FimW-mediated repression, we first sought to identify the proteins that regulate expression from the PfimW promoter. To answer this question, we measured the level of expression from the PfimW promoter in a {Delta}fimYZ mutant in which FimW, FimY, and FimZ were independently expressed using the aTc-inducible system. In the case of FimW and FimZ, expression had no effect on PfimW promoter activity (data not shown). However, in the case of FimY, we observed a significant increase in PfimW promoter activity (1,052 ± 381 relative fluorescence units [RFU]/OD [uninduced] versus 14,718 ± 1,032 RFU/OD [induced]). Similar results were also obtained when these experiments were performed with E. coli (data not shown). To identify the regulatory targets of FimW, we measured the expression of the PfimA, PfimZ, and PfimY promoters in a {Delta}fimW {Delta}fimYZ mutant in which FimW was expressed using the aTc-inducible system. In the cases of the PfimA and PfimZ promoters, we found that FimW expression had no effect. However, in the case of the PfimY promoter, FimW expression led to about a threefold decrease in PfimY activity (7,462 ± 319 RFU/OD [uninduced] versus 2,781 ± 188 RFU/OD [induced]). Based on these results, we conclude that FimY activates expression from the PfimW promoter and that FimW represses expression from the PfimY promoter.

The PfimU promoter is not regulated by FimW, FimY, or FimZ. Both fimY and fimZ contain rare arginine codons (AGA and AGG) and need fimU, a tRNA specific for rare arginine codons, for effective translation. In a {Delta}fimU mutant, PfimA activity was less than 10-fold compared to the wild-type levels (wild type, 16,723 ± 1,173 RFU/OD; the {Delta}fimU mutant, 1,389 ± 261 RFU/OD). The expression of FimY in the {Delta}fimU mutant using the aTc-inducible system, however, did not increase PfimA activity (988 ± 319 [uninduced] versus 1,343 ± 166 [induced]). Replacing the rare arginine codons in the fimY gene with consensus ones did restore PfimA activity to the wild-type levels (817 ± 73 RFU/OD [uninduced] versus 11,294 ± 462 RFU/OD [induced]). These experiments are consistent with previously published results (45) and indicate that fimU is essential for effective fimY translation.

As fimU has a strong effect on PfimA promoter activity, we hypothesized that it may be subject to regulation by the other proteins within the circuit. To test this hypothesis, we measured PfimU promoter activity in different regulatory mutants. Contrary to our hypothesis, we did not observe any change in PfimU promoter activity in any mutant (wild type, 26,717 ± 1,381 RFU/OD; the {Delta}fimZ mutant, 28,991 ± 2,164 RFU/OD; the {Delta}fimY mutant, 25,884 ± 1,983 RFU/OD; the {Delta}fimYZ mutant, 26,516 ± 1,772 RFU/OD; and the {Delta}fimW mutant, 24,829 ± 2,073 RFU/OD). Likewise, we did not observe any change in PfimU promoter activity when FimW, FimY, and FimZ were expressed using the aTc-inducible system in wild-type serovar Typhimurium or E. coli (data not shown). Based on these results, we conclude that the PfimU promoter is not regulated by any fim protein.

FimZ alone is able to regulate SPI1 gene expression. Previous studies have shown that both FimY and FimZ regulate SPI1 expression through their activation of the PhilE promoter (7). HilE, in turn, is known to bind HilD and repress the HilD-mediated activation of the PhilA, PhilC, PrtsA, and PhilD promoters (6, 20). To test which protein activates the PhilE promoter, we independently expressed FimY and FimZ in a {Delta}fimYZ mutant using the aTc-inducible system and then measured the level of expression from the PhilE promoter. Of the two, only FimZ was found to affect PhilE expression (1,089 ± 421 RFU/OD [uninduced] versus 17,654 ± 2,234 RFU/OD [induced]). Similar results were also observed for E. coli (data not shown).

We note that these results are contrary to those previously reported, for which it was shown that both FimY and FimZ were necessary for activation of the PhilE promoter (7). One possible explanation for the discrepancy involves how the two gene products were selectively expressed. In the original study, a DNA fragment containing the fimYZ gene cluster was cloned onto a plasmid and expressed using the tetracycline promoter. To study their relative effects, each gene was selectively inactivated using a universal translational terminator. As part of the PfimY promoter and the whole PfimZ promoter were left intact in their construct, transcriptional inference may have occurred between the various promoters. In our design, we selectively cloned each gene and then expressed it from an inducible promoter, eliminating any potential interfering effects from having the native promoters still present.

Dynamics of fim gene expression. Finally, we wished to investigate the dynamics of fim gene expression. We first measured PfimA promoter activity in the wild type and the {Delta}fimY, {Delta}fimZ, {Delta}fimYZ, and {Delta}fimW mutants using a microplate reader (Fig. 4A). Consistent with our end-point measurements, we found that the PfimA promoter was weakly expressed in the {Delta}fimY, {Delta}fimZ, and {Delta}fimYZ mutants. Likewise, expression was enhanced in a {Delta}fimW mutant. Note that the microplate experiments tell us only about the average response of the population and nothing about how individual cells are behaving. To test whether the cells were responding homogeneously, we also performed single-cell measurements of PfimA promoter activity at selected times in the wild type and a {Delta}fimW mutant using flow cytometry (Fig. 4B). Our results indicate that individual wild-type and {Delta}fimW mutant cells are responding homogeneously with respect to PfimA promoter activity at all times tested. In other words, we did not observe any phase variation or heterogeneity with regard to PfimA promoter activity in our kinetic experiments.


Figure 4
View larger version (20K):
[in this window]
[in a new window]

 
FIG. 4. Dynamics of PfimA promoter activity. (A) Population average PfimA activity as a function of time in the wild type and the {Delta}fimY, {Delta}fimZ, {Delta}fimYZ, and {Delta}fimW mutants. Data are averages of the results from a single experiment with an average of six independent cultures. The experiment was repeated thrice, and identical results were observed. (B) Histogram of single-cell PfimA promoter activity at selected times in the wild type and a {Delta}fimW mutant. Single-cell measurements of promoter activity were obtained using flow cytometry. Population distribution data are from a single experiment. The experiment was repeated thrice, and identical results were observed (data not shown).


arrow
DISCUSSION
 
In this work, we investigated the regulatory gene circuit controlling the expression of type I fimbriae in serovar Typhimurium. Using genetic approaches, we demonstrated that FimY and FimZ independently activate the PfimA promoter. Of the two, FimZ was found to be the dominant activator. We also found that FimY and FimZ strongly activate each other's expression and weakly activate their own expression. In addition to these two positive regulators, a third regulator, FimW, is known to repress fim gene expression. We found that FimW negatively regulates fim gene expression by repressing expression from the PfimY promoter. Furthermore, FimW participates in a negative feedback loop as FimY was found to enhance PfimW expression. Interestingly, these results suggest that FimY is both an activator and a repressor of fim gene expression, as it can directly activate the PfimZ, PfimY, and PfimA promoters and indirectly repress them by enhancing FimW expression. In addition to these regulators, type I fimbriation is also dependent on the expression of a rare arginine codon tRNA, fimU. However, our results showed that the PfimU promoter is not regulated by FimY, FimZ, or FimW. The results suggest that fimU does not play a role in the internal regulation of the circuit. Finally, we demonstrated that the previously observed coordinate regulation of SPI1 gene expression by the fim gene circuit (7) occurs through the activation of hilE expression by FimZ. Based on these results, we are able to propose the following model for the fim gene circuit in serovar Typhimurium (Fig. 5).


Figure 5
View larger version (13K):
[in this window]
[in a new window]

 
FIG. 5. Model for the type I fimbria gene circuit in serovar Typhimurium.

According to our model, the induction of the fim circuit begins with the activation of the PfimY and PfimZ promoters, resulting in small amounts of fimY and fimZ being expressed. FimY and FimZ then rapidly accumulate in the cell due to the positive feedback loop formed by the cross-activation of the PfimY and PfimZ promoters by these two proteins. The expression of the type I fimbrial structural genes from the PfimA promoter commences when the concentration of FimY and FimZ within the cell rises beyond a critical level. These two regulators can independently activate the PfimA promoter; however, their expression is correlated, as each activates the other's expression. Moreover, FimY and FimZ protein expression levels are controlled by a negative feedback loop involving FimW. In this loop, FimY activates the expression of the PfimW promoter, and FimW represses the expression of the PfimY promoter. We hypothesize that this negative feedback loop involving FimW prevents the runaway expression of FimY and FimZ arising from their participation in interacting positive feedback. Specifically, we hypothesize that when FimY and FimZ reach their optimum expression levels, the FimW negative feedback loop is activated and halts expression from the PfimY and PfimZ promoters.

While our model for the fim circuit explains internal regulation, it still does not explain how the circuit is activated. In particular, we do not know which factors induce the PfimY and PfimZ promoters. We suspect that these factors activate both promoters, as each alone exhibits some activity in a {Delta}fimYZ mutant (Fig. 1). In addition to these factors, another open question concerns whether fimU plays a role in regulating circuit dynamics. While it is tempting to speculate that fimU expression is tuned in response to environmental signals and thus affects circuit dynamics, more likely this gene is constitutively expressed like other tRNAs.

Our results also indicate that the FimW-mediated inhibition of fim gene expression is through repression of the PfimY promoter. Earlier reports suggested that FimW binds FimZ and somehow inhibits the FimZ-dependent activation of fim promoters (45). Moreover, FimW was not found to bind to the PfimW promoter. Based on these results, FimW would appear to repress the PfimY promoter by preventing FimZ from activating it. However, we found that FimW is able to repress the PfimY promoter in the absence of FimZ. Our results would suggest that FimW directly binds the PfimY promoter and represses transcription independently of FimZ. Consistent with our model, FimW has a C-terminal LuxR-type helix-turn-helix DNA domain (SM00421) (31). However, at this time we have no direct experimental support for such a mechanism. Moreover, an equally likely hypothesis is that repression by FimW is indirect. Further experiments are clearly required to determine the mechanism of FimW-mediated repression and distinguish between these different putative models.

A final unanswered question concerns the role of the positive and negative feedback loops in the fim gene circuit. Our initial hypothesis was that these feedback loops would result in bistability. In particular, interacting positive and negative feedback loops are known to be sufficient ingredients for bistability (23). This bistability could potentially explain the phase variation observed in type I fimbriation during growth in inducing conditions (35). To test whether the fim circuit exhibited bistability, we measured PfimA activity at single-cell resolution as a function of time. Contrary to our initial hypothesis, we did not observe a heterogeneous or switch-like response in induction, the telltale indicator of bistability. Rather, we observed a continuous or rheostat-like response in both the wild type and a {Delta}fimW mutant (3). One possibility is that there is a lack of correlation between fim gene expression and the production of type I fimbria in serovar Typhimurium (11). Another is that the environment may dictate the response characteristics. For example, under conditions different from those used in our study, Duguid and coworkers observed subpopulations of cells expressing type I fimbriae, indicative of phase variation (17). With these in mind, we hypothesize that the bacteria exhibit type I fimbria phase variation under specific environmental conditions and that the regulation of this process involves posttranscriptional mechanisms as well.


arrow
ACKNOWLEDGMENTS
 
We thank James Slauch and Philip Aldridge for strains and technical advice.

This work was partially supported by grants from the National Science Foundation and the National Institutes of Health.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, 600 S. Mathews Ave., Urbana, IL 61810. Phone: (217) 244-2247. Fax: (217) 333-5052. E-mail: chris{at}scs.uiuc.edu Back

{triangledown} Published ahead of print on 13 February 2009. Back

§ These authors contributed equally to this work. Back


arrow
REFERENCES
 
    1
  1. Abraham, J. M., C. S. Freitag, J. R. Clements, and B. I. Eisenstein. 1985. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc. Natl. Acad. Sci. USA 82:5724-5727.[Abstract/Free Full Text]
  2. 2
  3. Bajaj, V., C. Hwang, and C. A. Lee. 1995. hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes. Mol. Microbiol. 18:715-727.[CrossRef][Medline]
  4. 3
  5. Batchelor, E., T. J. Silhavy, and M. Goulian. 2004. Continuous control in bacterial regulatory circuits. J. Bacteriol. 186:7618-7625.[Abstract/Free Full Text]
  6. 4
  7. Baumler, A. J., R. M. Tsolis, and F. Heffron. 1996. Contribution of fimbrial operons to attachment to and invasion of epithelial cell lines by Salmonella typhimurium. Infect. Immun. 64:1862-1865.[Abstract]
  8. 5
  9. Baumler, A. J., R. M. Tsolis, and F. Heffron. 1997. Fimbrial adhesins of Salmonella typhimurium. Role in bacterial interactions with epithelial cells. Adv. Exp. Med. Biol. 412:149-158.[Medline]
  10. 6
  11. Baxter, M. A., T. F. Fahlen, R. L. Wilson, and B. D. Jones. 2003. HilE interacts with HilD and negatively regulates hilA transcription and expression of the Salmonella enterica serovar Typhimurium invasive phenotype. Infect. Immun. 71:1295-1305.[Abstract/Free Full Text]
  12. 7
  13. Baxter, M. A., and B. D. Jones. 2005. The fimYZ genes regulate Salmonella enterica serovar Typhimurium invasion in addition to type 1 fimbrial expression and bacterial motility. Infect. Immun. 73:1377-1385.[Abstract/Free Full Text]
  14. 8
  15. Boddicker, J. D., B. M. Knosp, and B. D. Jones. 2003. Transcription of the Salmonella invasion gene activator, hilA, requires HilD activation in the absence of negative regulators. J. Bacteriol. 185:525-533.[Abstract/Free Full Text]
  16. 9
  17. Buchanan, K., S. Falkow, R. A. Hull, and S. I. Hull. 1985. Frequency among Enterobacteriaceae of the DNA sequences encoding type 1 pili. J. Bacteriol. 162:799-803.[Abstract/Free Full Text]
  18. 10
  19. Cherepanov, P. P., and W. Wackernagel. 1995. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158:9-14.[CrossRef][Medline]
  20. 11
  21. Clegg, S., L. S. Hancox, and K.-S. Yeh. 1996. Salmonella typhimurium fimbrial phase variation and FimA expression. J. Bacteriol. 178:542-545.[Abstract/Free Full Text]
  22. 12
  23. Collazo, C. M., and J. E. Galan. 1997. The invasion-associated type-III protein secretion system in Salmonella—a review. Gene 192:51-59.[CrossRef][Medline]
  24. 13
  25. Cotter, P. A., and J. F. Miller. 1994. BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect. Immun. 62:3381-3390.[Abstract/Free Full Text]
  26. 14
  27. Darwin, K. H., and V. L. Miller. 1999. Molecular basis of the interaction of Salmonella with the intestinal mucosa. Clin. Microbiol. Rev. 12:405-428.[Abstract/Free Full Text]
  28. 15
  29. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97:6640-6645.[Abstract/Free Full Text]
  30. 16
  31. Davis, R. W., D. Botsein, and J. R. Roth. 1980. Advanced bacterial genetics: a manual for genetic engineering. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  32. 17
  33. Duguid, J. P., E. S. Anderson, and I. Campbell. 1966. Fimbriae and adhesive properties in Salmonellae. J. Pathol Bacteriol. 92:107-138.[CrossRef][Medline]
  34. 18
  35. Duguid, J. P., M. R. Darekar, and D. W. Wheater. 1976. Fimbriae and infectivity in Salmonella typhimurium. J. Med. Microbiol. 9:459-473.[Abstract/Free Full Text]
  36. 19
  37. Eichelberg, K., W. D. Hardt, and J. E. Galan. 1999. Characterization of SprA, an AraC-like transcriptional regulator encoded within the Salmonella typhimurium pathogenicity island 1. Mol. Microbiol. 33:139-152.[CrossRef][Medline]
  38. 20
  39. Ellermeier, C. D., J. R. Ellermeier, and J. M. Slauch. 2005. HilD, HilC and RtsA constitute a feed forward loop that controls expression of the SPI1 type three secretion system regulator hilA in Salmonella enterica serovar Typhimurium. Mol. Microbiol. 57:691-705.[CrossRef][Medline]
  40. 21
  41. Ellermeier, C. D., and J. M. Slauch. 2003. RtsA and RtsB coordinately regulate expression of the invasion and flagellar genes in Salmonella enterica serovar Typhimurium. J. Bacteriol. 185:5096-5108.[Abstract/Free Full Text]
  42. 22
  43. Fahlen, T. F., N. Mathur, and B. D. Jones. 2000. Identification and characterization of mutants with increased expression of hilA, the invasion gene transcriptional activator of Salmonella typhimurium. FEMS Immunol. Med. Microbiol. 28:25-35.[CrossRef][Medline]
  44. 23
  45. Ferrell, J. E. 2002. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr. Opin. Cell Biol. 14:140-148.[CrossRef][Medline]
  46. 24
  47. Gally, D. L., J. Leathart, and I. C. Blomfield. 1996. Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12. Mol. Microbiol. 21:725-738.[CrossRef][Medline]
  48. 25
  49. Haldimann, A., and B. L. Wanner. 2001. Conditional-replication, integration, excision, and retrieval plasmid-host systems for gene structure-function studies of bacteria. J. Bacteriol. 183:6384-6393.[Abstract/Free Full Text]
  50. 26
  51. Hancox, L. S., K. S. Yeh, and S. Clegg. 1997. Construction and characterization of type 1 non-fimbriate and non-adhesive mutants of Salmonella typhimurium. FEMS Immunol. Med. Microbiol. 19:289-296.[CrossRef][Medline]
  52. 27
  53. Klemm, P. 1984. The fimA gene encoding the type-1 fimbrial subunit of Escherichia coli. Nucleotide sequence and primary structure of the protein. Eur. J. Biochem. 143:395-399.[Medline]
  54. 28
  55. Klemm, P. 1986. Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J. 5:1389-1393.[Medline]
  56. 29
  57. Labbe, D., J. Garnon, and P. C. Lau. 1997. Characterization of the genes encoding a receptor-like histidine kinase and a cognate response regulator from a biphenyl/polychlorobiphenyl-degrading bacterium, Rhodococcus sp. strain M5. J. Bacteriol. 179:2772-2776.
  58. 30
  59. Lau, P. C., Y. Wang, A. Patel, D. Labbe, H. Bergeron, R. Brousseau, Y. Konishi, and M. Rawlings. 1997. A bacterial basic region leucine zipper histidine kinase regulating toluene degradation. Proc. Natl. Acad. Sci. USA 94:1453-1458.[Abstract/Free Full Text]
  60. 31
  61. Letunic, I., R. R. Copley, B. Pils, S. Pinkert, J. Schultz, and P. Bork. 2006. SMART 5: domains in the context of genomes and networks. Nucleic Acids Res. 34:257-260.[CrossRef]
  62. 32
  63. Lucas, R. L., and C. A. Lee. 2001. Roles of hilC and hilD in regulation of hilA expression in Salmonella enterica serovar Typhimurium. J. Bacteriol. 183:2733-2745.[Abstract/Free Full Text]
  64. 33
  65. Lutz, R., and H. Bujard. 1997. Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res. 25:1203-1210.[Abstract/Free Full Text]
  66. 34
  67. Nagai, T., K. Ibata, E. S. Park, M. Kubota, K. Mikoshiba, and A. Miyawaki. 2002. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20:87-90.[CrossRef][Medline]
  68. 35
  69. Old, D. C., and J. P. Duguid. 1970. Selective outgrowth of fimbriate bacteria in static liquid medium. J. Bacteriol. 103:447-456.[Abstract/Free Full Text]
  70. 36
  71. Piknova, L., E. Kaclikova, D. Pangallo, B. Polek, and T. Kuchta. 2005. Quantification of Salmonella by 5'-nuclease real-time polymerase chain reaction targeted to fimC gene. Curr. Microbiol. 50:38-42.[CrossRef][Medline]
  72. 37
  73. Purcell, B. K., J. Pruckler, and S. Clegg. 1987. Nucleotide sequences of the genes encoding type 1 fimbrial subunits of Klebsiella pneumoniae and Salmonella typhimurium. J. Bacteriol. 169:5831-5834.[Abstract/Free Full Text]
  74. 38
  75. Rossolini, G. M., P. Muscas, A. Chiesurin, and G. Satta. 1993. Analysis of the Salmonella fim gene cluster: identification of a new gene (fimI) encoding a fimbrin-like protein and located downstream from the fimA gene. FEMS Microbiol. Lett. 114:259-265.[CrossRef][Medline]
  76. 39
  77. Saini, S., J. D. Brown, P. D. Aldridge, and C. V. Rao. 2008. FliZ is a posttranslational activator of FlhD4C2-dependent flagellar gene expression. J. Bacteriol. 190:4979-4988.[Abstract/Free Full Text]
  78. 40
  79. Schechter, L. M., S. M. Damrauer, and C. A. Lee. 1999. Two AraC/XylS family members can independently counteract the effect of repressing sequences upstream of the hilA promoter. Mol. Microbiol. 32:629-642.[CrossRef][Medline]
  80. 41
  81. Schechter, L. M., and C. A. Lee. 2001. AraC/XylS family members, HilC and HilD, directly bind and derepress the Salmonella typhimurium hilA promoter. Mol. Microbiol. 40:1289-1299.[CrossRef][Medline]
  82. 42
  83. Swenson, D. L., K. J. Kim, E. W. Six, and S. Clegg. 1994. The gene fimU affects expression of Salmonella typhimurium type 1 fimbriae and is related to the Escherichia coli tRNA gene argU. Mol. Gen. Genet. 244:216-218.[Medline]
  84. 43
  85. Tavendale, A., C. K. Jardine, D. C. Old, and J. P. Duguid. 1983. Haemagglutinins and adhesion of Salmonella typhimurium to HEp2 and HeLa cells. J. Med. Microbiol. 16:371-380.[Abstract/Free Full Text]
  86. 44
  87. Tinker, J. K., and S. Clegg. 2000. Characterization of FimY as a coactivator of type 1 fimbrial expression in Salmonella enterica serovar Typhimurium. Infect. Immun. 68:3305-3313.[Abstract/Free Full Text]
  88. 45
  89. Tinker, J. K., and S. Clegg. 2001. Control of FimY translation and type 1 fimbrial production by the arginine tRNA encoded by fimU in Salmonella enterica serovar Typhimurium. Mol. Microbiol. 40:757-768.[CrossRef][Medline]
  90. 46
  91. Tinker, J. K., L. S. Hancox, and S. Clegg. 2001. FimW is a negative regulator affecting type 1 fimbrial expression in Salmonella enterica serovar Typhimurium. J. Bacteriol. 183:435-442.[Abstract/Free Full Text]
  92. 47
  93. van der Velden, A. W., A. J. Baumler, R. M. Tsolis, and F. Heffron. 1998. Multiple fimbrial adhesins are required for full virulence of Salmonella typhimurium in mice. Infect. Immun. 66:2803-2808.[Abstract/Free Full Text]
  94. 48
  95. Yeh, K. S., L. S. Hancox, and S. Clegg. 1995. Construction and characterization of a fimZ mutant of Salmonella typhimurium. J. Bacteriol. 177:6861-6865.[Abstract/Free Full Text]
  96. 49
  97. Yeh, K. S., J. K. Tinker, and S. Clegg. 2002. FimZ binds the Salmonella typhimurium fimA promoter region and may regulate its own expression with FimY. Microbiol. Immunol. 46:1-10.[Medline]


Journal of Bacteriology, May 2009, p. 3003-3010, Vol. 191, No. 9
0021-9193/09/$08.00+0     doi:10.1128/JB.01694-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saini, S.
Right arrow Articles by Rao, C. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saini, S.
Right arrow Articles by Rao, C. V.